Rockwell Medical (RMTI) Projected to Post Earnings on Thursday

Rockwell Medical (NASDAQ:RMTI) is projected to release its earnings data before the market opens on Thursday, March 20th. Analysts expect Rockwell Medical to post earnings of $0.02 per share and revenue of $23.65 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Rockwell Medical Trading Up 4.1 %

Rockwell Medical stock opened at $1.77 on Tuesday. The stock has a 50-day simple moving average of $1.90 and a 200 day simple moving average of $2.64. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. The stock has a market capitalization of $57.20 million, a P/E ratio of -35.40 and a beta of 1.55. Rockwell Medical has a 52 week low of $1.36 and a 52 week high of $5.15.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on RMTI. HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Rockwell Medical in a research note on Monday, December 23rd. StockNews.com lowered shares of Rockwell Medical from a “buy” rating to a “hold” rating in a report on Friday, December 20th.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.